Resistance to Insulin in Patients with Gitelman Syndrome and a Subtle Intermediate Phenotype in Heterozygous Carriers: A Cross-Sectional Study
Anne Blanchard(Délégation Paris 5), Rosa Vargas‐Poussou(Hôpital Européen Georges-Pompidou), Jean‐Philippe Haymann(Sorbonne Université), Pascal Houillier(Inserm), Olivier Devuyst(Cliniques Universitaires Saint-Luc), Pierre‐Yves Courand(Université Claude Bernard Lyon 1), Armelle Arnoux(Hôpital Européen Georges-Pompidou), Marion Vallet(Université Toulouse III - Paul Sabatier), Xavier Jeunemaı̂tre(Délégation Paris 5), Marguerite Hureaux(Hôpital Européen Georges-Pompidou), Julien Allard(Sorbonne Université), Michel Azizi(Inserm), Pierre‐Hadrien Becker(Assistance Publique – Hôpitaux de Paris), Laurence Dubourg(Lyon 1 Université), Renaud de la Faille(Hôpital Pellegrin), Damien Bergerot(Inserm), Aurelie Dinut(Inserm), Stéphanie Baron(Délégation Paris 5), Ivan Tack(Inserm)
Cited by 52
Related Papers
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
The 2017 international classification of the Ehlers–Danlos syndromes
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|1.9k
Evolving importance of kidney disease: from subspecialty to global health burden
|The Lancet|2013|1.2k
SDHA is a tumor suppressor gene causing paraganglioma
|Human Molecular Genetics|2010|651